ATORVASTATIN

Clinical trials for ATORVASTATIN explained in plain language.

Never miss a new study

Get alerted when new ATORVASTATIN trials appear

Sign up with your email to follow new studies for ATORVASTATIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Personalized combo therapy aims to overcome drug resistance in kidney cancer

Disease control Not yet recruiting

This study tests whether adding the cholesterol drug atorvastatin to standard targeted therapy (axitinib) and immunotherapy (toripalimab) can help people with advanced kidney cancer who are not responding well to treatment. The drug combination is guided by lab tests on patient-d…

Matched conditions: ATORVASTATIN

Phase: PHASE1, PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC

ATORVASTATIN

Get alerted when new ATORVASTATIN trials appear

Personalized combo therapy aims to overcome drug resistance in kidney cancer